期刊文献+

B型利钠肽在慢性心力衰竭患者预后中的价值 被引量:5

The prognostic value of serum B-type natriuretic peptide for prognosis in patients with congestive heart failure
暂未订购
导出
摘要 目的探讨B型利钠肽(BNP)水平在预测慢性心力衰竭(CHF)患者预后中的价值。方法对98例CHF患者进行随访[(17.62±3.71)月],记录发生的心血管事件,分为心血管事件组与非事件组,分析不同BNP水平在预测CHF患者预后中的价值。结果事件组的年龄、收缩压和左心室舒张末内经(LVEDD)明显高于非事件组(P<0.05),BNP水平[(1156.85±838.16)ng/L]显著高于非事件组[(716.45±182.07)ng/L](P<0.01),左室射血分数(LVEF)[(40.85±6.72)%]显著低于非事件组的[(46.42±5.64)%](P<0.01)。以98例CHF患者BNP水平的中位数758 ng/L为分组界值,通过Kaplan-Meier法作不同BNP水平患者在随访期间心血管事件发生率曲线,可见BNP<758 ng/L组的随访曲线明显高于BNP>758 ng/L组,计算Log-rank值为15.22(P=0.000);以BNP中位数对CHF患者进行危险分层,中位数以上患者发生心血管事件的风险是中位数以下患者的3.1倍(P<0.01)。结论发生心血管事件患者的BNP水平显著增高,BNP水平在预测CHF患者的预后中有重要价值。 Objective To observe the prediction prognosis value of B-type natriuretic peptide (BNP)on prognosis for patients with congestive heart failure (CHF).Methods Ninety-eight patients with CHF in our depart-ment were followed up for mean 1 7.6 months.Patints with CHF were divided into cardiovascular events group and non-cardiovascular events group,and the prognostic value of BNP on outcome for patients with CHF were analysed. Results Compared with non-cardiovascular events group,age,systolic blood presssure,and LVEDD were higher in the cardiovascular events group(P 〈0.05),serum BNP level was increased(P 〈0.01 ),left ventricular ejection frac-tions was decreased in the cardiovascular events group(P 〈0.01 ).Kaplan Meier cumulative survival analysis showed that the survival rate of patients with BNP 〈758 ng/L(median)was much higher than that of patients with BNP 〉758 ng/L(P 〈0.01 ).The event risk was 3.1 times higher in patients with BNP level above median compared with pa-tients with BNP level under median(P 〈0.01 ).Conclusion Serum BNP level is significantly higher in patients with cardiovascular events,serum BNP has important prognosis value for patients with CHF.
出处 《中国临床保健杂志》 CAS 2014年第6期579-581,I0007,共4页 Chinese Journal of Clinical Healthcare
关键词 心力衰竭 利钠肽 随访研究 Heart failure Natriuretic Peptide,Brain Follow-Up Studies
  • 相关文献

参考文献6

  • 1Hunt SA,Abraham WT, Feldman AM, et al. 2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in A- dults A Report of the American College of Cardiology Foundation/American Hcart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation [J]. J Am Coll Cardi01,2009,53(15) :e1-e90.
  • 2冷文修,何昆仑,范利,梁致如.BNP和NT—proBNP在鉴别舒张性心力衰竭中的应用研究[J].中华检验医学杂志,2010,33(4):328-332. 被引量:63
  • 3Chen K, Jiang R J, Wang CQ, et al. Predictive value of plasma galectin-3 in patients with chronic heart failure [J]. Eur Rev Med Pharmacol Sci,2013,17 (8) : 1005- 1011.
  • 4Mockel M, Muller R, Vollert JO, et al. Role of N-terminal Pro-B-Type natriuretie peptide in risk stratification in pa- tients presenting in the emergency room [ J ]. Clin Chem, 2005,51 (9) :1624-1631.
  • 5Berger R, Huelsman M, Stecker K, el al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure [ J ]. Circulation,2002,105 ( 20 ) : 2391-2396.
  • 6Lok D J, Klip IT, Lok SI, et al. Incremental prognostic power of novel biomarkers (growth-differentiation factor- 15, high-sensitivity C-reactive protein, galectin-3, and high-sensitivity troponin-t ) in patients with advanced chronic heart failure [ J ]. Am J Cardiol, 2013,112 ( 6 ) : 831-837.

二级参考文献10

  • 1徐国宾,史晓敏.B型钠尿肽及N末端B型钠尿肽原在临床应用中值得关注的几个问题[J].中华检验医学杂志,2006,29(1):9-11. 被引量:71
  • 2Hunt SA,Abraham WT,Feldman AM,et al.2009 Focused update incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation.J Am Coll Cardiol,2009,53:e1-e90.
  • 3Paulus WJ,Tschopo C,Sanderson JE,et al.How to diagnose diastolic heart failure:a consensus statement on the diagnosis of heart failure with normal left ventricutar ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology.Eur Heart J,2007,28:2539-2550.
  • 4Yasue H,Yoshimura M,Sumida H,et al.Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-typo natriuretic peptide in normal subjects and patients with heart failure.Circulation,1994,90:195-203.
  • 5Maeda K,Tsutamoto T,Wada A,et al.Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular ysfunction.Am Heart J,1998,135:825-832.
  • 6Maisel AS,Krishnaswamy P,Nowak RM,et al.Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.N Engl J Med,2002,347:161-167.
  • 7Scardovi AB,Coletta C,Aspromonte N,et al.Brain natriuretic peptide plasma level is a rehable indicator of advanced diastolic dysfunction in patients with chronic heart failure.Eur J Echecardiogr,2007,8:30-36.
  • 8Grewal J,McKelvie R,Lonn E,et al.BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction.Eur J Heart Fail,2008,10:252-259.
  • 9Angeja BG,Grossman W.Evaluation and management of diastolic heart failure.Circulation,2003,107:659-663.
  • 10赵玉生,田亚平,高伟,刘红鹰,原新红,陈瑞,王士雯,程芮,刘光华(.心血管病患者血浆N-端脑钠素前体浓度与心功能的关系[J].中国循环杂志,2004,19(1):46-49. 被引量:14

共引文献62

同被引文献43

  • 1林曙光,王玲.治疗心力衰竭的循证医学进展[J].国际心血管病杂志,2007,34(5):307-310. 被引量:18
  • 2陆再英,钟南山.内科学[M].7版.北京:人民卫生出版社,2008:775.
  • 3高润霖,胡大一.心血管病诊治新进展[M].北京:人民军医出版社,2011.178-183.
  • 4Yu XJ,Suo YP,Qi J.Interaction between ATl receptor and NF-κB in hypothalamic paraventricular nucleus contributes to oxidative stress and sympathoexcitation by modulating neurotransmitters in heart failure[J].Cardiovasc Texaco,2013,12(3):496-498.
  • 5Konstam MA,Neaton JD,Poole-Wilson PA,et al.Comparison of losartan and captopril on heart failure-related outcomes and symptoms from the losartan heart failure survival study(ELITEⅡ)[J].Am Heart J,2005,150(1):123-131.
  • 6Kendall MJ,Lynch KP,Hjalmarson A,et al.Beta-blockers and sudden cardiac death[J].Ann Intern Med,1995,123(5):358-367.
  • 7赵水平,胡大一.心血管病诊疗指南解读[M].3版.北京:人民卫生出版社,2010:80-88.
  • 8Fitterman N,Amin A.Brain Natriuretic Peptide:Chronic Heart Failure and More?[J] .Hospital Med Clin,2012,(3):e289-e299.
  • 9无.慢性心力衰竭诊断治疗指南[J].中华心血管病杂志,2007,35(12):1076-1095. 被引量:3755
  • 10Roger VL. Epidemiology of Heart Failure [J]. Cire Res, 2013,113(6) :646 -659.

引证文献5

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部